Icon

KEPPRA XR (nda022285)- (500MG,750MG)

LEVETIRACETAM UCB INC
500MG,750MG
Yes No
2029-Mar-17 Expired
None None
None No
KEPPRA XR is indicated for the treatment of partial-onset seizures in patients 12 years of age and older.
13 0 8
Total Other Developers 12
Drugs with Suitability Yes
500MG ** ** Up - 6
750MG ** ** Up - 6
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** *** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** ***** *** ***** ******* *********** **** **. **-*, ***** *-*, ***** ********** ****, *****, ********, *** ******, ***** (***) ***
****** *** ***** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ******** *** ******** ****** ************** **., ***. *********** ******* ****, ******, ******** ******, ***** (***) ***
****** **** ********** ******************** ****. *********** ** ********* ****, *******, ******* *** ***, ****** (***) ***
****** **** ********** ******** ****** ******* ******* *** *********** ****-**, **.**'*.**,**,**,**,** ** **,***&***, ************** * & **.** *,*,****,**,**,**,**&**, ************ *, *********** ******, **********, ****** ******* ******, ***** (***) ***
****** ******* ****** *** ******* ***************, ***. *********** ** ***** *****, *********, *** **** (**) *****-****, ****** ****** (***) ***
****** ******** ******* ************ ******* *** *********** **** *, **. **: ***, ***, ***, ***/*, **************** ****** ****, *********** *******, *********** ******,, **********, ********* ***** ******, ***** (***) ***
****** ******** ******** ******** ************** **., *** *********** **, ****** ****, ****** ****, ******* ********, ******, ******** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.